Robeco Healthy Living I Cap EUR
Rating and Score (On 30/06/2026)
Rating
FIDA
Rating
ESG
FIDA Category
***Some functions are not available in this version.***
Register for free to unlock functions
Static data
Name | Robeco Healthy Living I Cap EUR |
Typology | Funds and Sicav |
ISIN Code | LU2146190165 |
Sicav | Robeco Capital Growth Funds |
Registration country | - |
Country authorised for sale | |
Asset manager | |
Address | Weena 850 NL-3014 Rotterdam |
Phone | |
Web site | |
FIDA Category | |
Assogestioni category | |
EFAMA Category | Equity Health Care |
Priips | Yes |
Official benchmark | 100.00% - MSCI World Net TR (EUR) |
Start Date placement | 30/10/2020 |
Search by currency | Eur - euro |
Quotation currency | Eur - euro |
Status | Active |
Distribution policy | No |
Total asset value at 30/07/2026 | - |
Assets of portfolio as of 30/07/2026 | 130.12 mln EUR |
Documentation |
Quotation evolution (From 28/07/2023 On 30/07/2026)
273.55
3.14
%
30/07/2026
Loading data
Quote
Quotation currency | Eur - euro |
Quotation frequency | Daily |
Last quotation | €273.55 (30/07/2026) |
% change | |
Last Price in Euro | €273.55 |
Investment Objective
Robeco Healthy Living is an actively managed fund that invests globally in companies that promote good health and well-being and contribute to an efficient healthcare system including also products or services linked to the prevention of disease via eating healthier diets, exercising regularly and reducing the spread of infectious diseases with hygiene measures. The selection of these stocks is based on fundamental analysis. The fund has sustainable investment as its objective, within the meaning of Article 9 of the Regulation (EU) 2019/2088 of 27 November 2019 on Sustainability-related disclosures in the financial sector. The fund's objective is also to achieve a better return than the Benchmark. The strategy integrates sustainability criteria as part of the stock selection process and through a theme-specific sustainability assessment. The portfolio is built on the basis of an eligible investment universe that includes companies whose business models contribute to the thematic investment objectives. The assessment regarding relevant SDGs uses an internally developed framework, more information on which can be obtained at www.robeco.com/si. The fund has sustainable investment as its objective within the meaning of Article 9 of the European Sustainable Finance Disclosure Regulation. The fund aims to mitigate the rising incidence of lifestyle diseases and increasing healthcare costs, by investing in companies that provide technologies, products or services, medical treatments linked to the prevention of disease and reducing the spread of infectious diseases. This is done by investing in companies that mainly advance the following UN Sustainable Development Goals (UN SDGs): Good health and well-being, Zero Hunger, and Clean water and sanitation. The fund integrates ESG (Environmental, Social and Governance) factors in the investment process and applies Robeco's Good Governance policy. The fund applies sustainability indicators, including but not limited to, normati |
Tax system
PIR compliant | No |
PEA compliant | No |
PEA-PME compliant | No |
Company registry
Asset manager | |
Phone | |
Web site | |
Address | Weena 850 NL-3014 Rotterdam |
The data and information covered by the Service are for the exclusive internal use of the User and may neither be transferred to third parties, nor circulated, disclosed or allowed to be disclosed, nor used on external information systems, without the written consent of FIDA and, when necessary, of the information sources.
